MALATHION 57%

Malathion 57% Product Label - Control Solutions, Inc. Malathion 57% Product Label - Control Solutions, Inc.

epestsupply.com
from epestsupply.com More from this publisher
26.09.2015 Views

FIRST AID (continued) IF IN EYES: • Hold eye open and rinse slowly and gently with water for 15- 20 minutes. • Remove contact lenses, if present, after the first 5 minutes, then continue rinsing eye. • Call a poison control center or doctor for treatment advice. Have the product container or label with you when calling a poison control center or doctor, or going for treatment. You may also contact SafetyCall® International 1-866-897-8050 for emergency medical treatment information. NOTE TO PHYSICIAN: Malathion is a cholinesterase inhibitor affecting the central and peripheral nervous systems and producing cardiac and respiratory depression. Antidote: Administer atropine sulphate in large doses, TWO to FOUR mg intravenously or intramuscularly as soon as cyanosis is overcome. Repeat at 5 to 10 minute intervals until signs of atropinization appear. 2-PAM chloride is a pharmacological antidote and may be administered as an adjunct to, but not a substitute for, atropine, which is a symptomatic and often lifesaving antidote. DO NOT GIVE MORPHINE OR TRANQUILIZERS. At first sign of pulmonary edema, the patient should be given supplemental oxygen and treated symptomatically. Continued absorption of malathion may occur and relapse may occur after initial improvement. VERY CLOSE SUPERVISION OF THE PATIENT IS INDICATED FOR AT LEAST 48 HOURS. Contains Petroleum Distillate. May pose an aspiration pneumonia hazard. 3

PRECAUTIONARY STATEMENTS HAZARDS TO HUMANS & DOMESTIC ANIMALS WARNING Causes substantial but temporary eye injury. Harmful if swallowed. Harmful if absorbed through skin. Do not get in eyes or on clothing. Avoid contact with skin, eyes or clothing. Prolonged or frequently repeated skin contact may cause allergic reactions in some individuals. PERSONAL PROTECTIVE EQUIPMENT (PPE): Some materials that are chemical-resistant to this product are barrier laminate, butyl rubber, nitrile rubber, or viton. If you want more options, follow the instructions for category F on an EPA chemical-resistance category selection chart. For all formulations and use patterns – mixers, loaders, applicators, flaggers, and other handlers must wear: • long sleeved shirt and long pants • shoes and socks • chemical resistant gloves (pilots must wear chemical resistant gloves only when entering or exiting the aircraft) For all dip applications – mixers, loaders, and applicators must wear: • long sleeved shirt and long pants • shoes and socks • chemical resistant gloves • chemical resistant apron For all air blast applications – applicators must wear: • long sleeved shirt and long pants • shoes and socks 4

FIRST AID (continued)<br />

IF IN EYES: • Hold eye open and rinse slowly<br />

and gently with water for 15-<br />

20 minutes.<br />

• Remove contact lenses,<br />

if present, after the first<br />

5 minutes, then continue<br />

rinsing eye.<br />

• Call a poison control center or<br />

doctor for treatment advice.<br />

Have the product container or label with you when<br />

calling a poison control center or doctor, or going<br />

for treatment. You may also contact SafetyCall®<br />

International 1-866-897-8050 for emergency<br />

medical treatment information.<br />

NOTE TO PHYSICIAN: Malathion is a<br />

cholinesterase inhibitor affecting the central<br />

and peripheral nervous systems and producing<br />

cardiac and respiratory depression. Antidote:<br />

Administer atropine sulphate in large doses, TWO<br />

to FOUR mg intravenously or intramuscularly as<br />

soon as cyanosis is overcome. Repeat at 5 to<br />

10 minute intervals until signs of atropinization<br />

appear. 2-PAM chloride is a pharmacological<br />

antidote and may be administered as an adjunct<br />

to, but not a substitute for, atropine, which is a<br />

symptomatic and often lifesaving antidote. DO<br />

NOT GIVE MORPHINE OR TRANQUILIZERS.<br />

At first sign of pulmonary edema, the patient<br />

should be given supplemental oxygen and treated<br />

symptomatically. Continued absorption of<br />

malathion may occur and relapse may occur after<br />

initial improvement. VERY CLOSE SUPERVISION<br />

OF THE PATIENT IS INDICATED FOR AT LEAST<br />

48 HOURS. Contains Petroleum Distillate. May<br />

pose an aspiration pneumonia hazard.<br />

3

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!